Suva LJ - Search Results

1

Marguiles AG, Klimberg VS, Bhattacharrya S, Gaddy D, Suva LJ. Marguiles AG, et al. Among authors: suva lj. Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6217s-6221s. doi: 10.1158/1078-0432.CCR-06-1070. Clin Cancer Res. 2006. PMID: 17062704 Review.

2

Breast cancer metastasis to bone: it is not all about PTHrP.

Bendre M, Gaddy D, Nicholas RW, Suva LJ. Bendre M, et al. Among authors: suva lj. Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S39-45. doi: 10.1097/01.blo.0000093844.72468.f4. Clin Orthop Relat Res. 2003. PMID: 14600591 Review.

3

Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.

Bendre MS, Margulies AG, Walser B, Akel NS, Bhattacharrya S, Skinner RA, Swain F, Ramani V, Mohammad KS, Wessner LL, Martinez A, Guise TA, Chirgwin JM, Gaddy D, Suva LJ. Bendre MS, et al. Among authors: suva lj. Cancer Res. 2005 Dec 1;65(23):11001-9. doi: 10.1158/0008-5472.CAN-05-2630. Cancer Res. 2005. PMID: 16322249

4

Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease.

Bendre MS, Montague DC, Peery T, Akel NS, Gaddy D, Suva LJ. Bendre MS, et al. Among authors: suva lj. Bone. 2003 Jul;33(1):28-37. doi: 10.1016/s8756-3282(03)00086-3. Bone. 2003. PMID: 12919697

5

Regulation of bone mass by mechanical loading: microarchitecture and genetics.

Suva LJ, Gaddy D, Perrien DS, Thomas RL, Findlay DM. Suva LJ, et al. Curr Osteoporos Rep. 2005 Jun;3(2):46-51. doi: 10.1007/s11914-005-0003-0. Curr Osteoporos Rep. 2005. PMID: 16036101 Review.

6

Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease.

Pennisi A, Li X, Ling W, Khan S, Gaddy D, Suva LJ, Barlogie B, Shaughnessy JD, Aziz N, Yaccoby S. Pennisi A, et al. Among authors: suva lj. Br J Haematol. 2009 Jun;145(6):775-87. doi: 10.1111/j.1365-2141.2009.07696.x. Epub 2009 Apr 8. Br J Haematol. 2009. PMID: 19388929 Free PMC article.

7

Identification of PTHrP(12-48) as a plasma biomarker associated with breast cancer bone metastasis.

Washam CL, Byrum SD, Leitzel K, Ali SM, Tackett AJ, Gaddy D, Sundermann SE, Lipton A, Suva LJ. Washam CL, et al. Among authors: suva lj. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):972-83. doi: 10.1158/1055-9965.EPI-12-1318-T. Epub 2013 Mar 5. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23462923 Free PMC article.

8

The best of both worlds - managing the cancer, saving the bone.

Makhoul I, Montgomery CO, Gaddy D, Suva LJ. Makhoul I, et al. Among authors: suva lj. Nat Rev Endocrinol. 2016 Jan;12(1):29-42. doi: 10.1038/nrendo.2015.185. Epub 2015 Oct 27. Nat Rev Endocrinol. 2016. PMID: 26503674 Free PMC article. Review.

9

PTHrP(12-48) Modulates the Bone Marrow Microenvironment and Suppresses Human Osteoclast Differentiation and Lifespan.

Kamalakar A, Washam CL, Akel NS, Allen BJ, Williams DK, Swain FL, Leitzel K, Lipton A, Gaddy D, Suva LJ. Kamalakar A, et al. Among authors: suva lj. J Bone Miner Res. 2017 Jul;32(7):1421-1431. doi: 10.1002/jbmr.3142. Epub 2017 Apr 19. J Bone Miner Res. 2017. PMID: 28370412 Free PMC article.

10

Bone is a target for the antidiabetic compound rosiglitazone.

Rzonca SO, Suva LJ, Gaddy D, Montague DC, Lecka-Czernik B. Rzonca SO, et al. Among authors: suva lj. Endocrinology. 2004 Jan;145(1):401-6. doi: 10.1210/en.2003-0746. Epub 2003 Sep 18. Endocrinology. 2004. PMID: 14500573 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page